paclitaxel has been researched along with Hepatoblastoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avgoustakis, K; Bikiaris, D; Karavelidis, V | 1 |
Armeanu-Ebinger, S; Eicher, C; Fuchs, J; Kirchner, B; Lieber, J; Warmann, SW; Wenz, J | 1 |
Cederbaum, AI; Holownia, A | 1 |
Fuchs, J; Habild, G; Haindl, J; Knop, E; Leuschner, I; Schweinitz, DV | 1 |
Cheng, SC; Luo, D; Xie, H; Xie, Y | 1 |
5 other study(ies) available for paclitaxel and Hepatoblastoma
Article | Year |
---|---|
New thermosensitive nanoparticles prepared by biocompatible pegylated aliphatic polyester block copolymers for local cancer treatment.
Topics: Adipates; Antineoplastic Agents; Biocompatible Materials; Carcinoma; Drug Delivery Systems; Female; Fever; HeLa Cells; Hep G2 Cells; Hepatoblastoma; Hot Temperature; Humans; Liver Neoplasms; Nanocapsules; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Polypropylenes; Uterine Cervical Neoplasms | 2015 |
The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomimetic Materials; Biphenyl Compounds; Cell Growth Processes; Cell Line, Tumor; Drug Synergism; Hepatoblastoma; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Mice, SCID; Nitrophenols; Paclitaxel; Piperazines; Sulfonamides; Xenograft Model Antitumor Assays | 2011 |
Threshold for antiproliferative and proapoptotic activity of ttaxol in HepG2 cells expressing human CYP3A4: effect of P-glycoprotein transporters.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochromes c; Dose-Response Relationship, Drug; Hepatoblastoma; Humans; Ketoconazole; Necrosis; Paclitaxel; RNA, Messenger | 2003 |
Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Division; Child, Preschool; Disease Models, Animal; Female; Hepatoblastoma; Humans; Immunohistochemistry; Infant; Liver Neoplasms; Mice; Mice, Nude; Paclitaxel; Transplantation, Heterologous; Tubulin | 1999 |
Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Blotting, Western; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Genes, bcl-2; Hepatoblastoma; Humans; Inhibitory Concentration 50; Liver Neoplasms; Paclitaxel; Plasmids; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Time Factors; Transfection; Tumor Cells, Cultured | 2000 |